- Inhibits endothelin (ET) receptor
- Inhibits ET biosynthesis
- Modulates redox-sensitive transcription factors
Competition: Darusentan (Gilead), Bosentan (Actelion), Ambrisentan (Gilead): Inhibit ET receptor only |
- More effective block of ET signaling
- Reduced inflammation and oxidative stress in patients
|
